Literature DB >> 1538792

Binding characteristics and functional G protein coupling of muscarinic acetylcholine receptors in rat duodenum smooth muscle membranes.

C Liebmann1, S Nawrath, M Schnittler, H Schubert, K H Jakobs.   

Abstract

The non-selective labelled antagonist [3H]N-methyl-scopolamine ([3H]NMS) was used to identify muscarinic acetylcholine receptors in rat duodenum smooth muscle membranes. Saturation and kinetic experiments revealed a binding site with a KD-value of 0.2-0.3 nmol/l and a receptor concentration (Bmax) of 100 fmol/mg protein. The affinities of eight selective muscarinic antagonists were determined and compared with those at M1 (rat cerebral cortex), M2 (rat heart), M3 (rat submandibular gland) and M4 (data from Dörje et al. 1991) receptors. The "M2-selective" agent AF-DX 116, the group of "M2/M4-selective" compounds himbacine, AF-DX 384, AQ-RA 741 and methoctramine but also the "M3-selective" HHSiD showed affinities corresponding to M2 and/or M4 sites. The intermediate affinity of 4-DAMP favours a mixed M2/M4 receptor population mainly containing M2 receptors. Two compounds, pirenzepine and AQ-RA 741, displayed biphasic displacement curves indicating the presence of a small population of putative M1 receptors. The rat duodenum antagonist binding profile, however, is not consistent with the presence of M3 receptors. We further demonstrate a concentration-dependent stimulation of [35S]GTP[S] binding to duodenal G proteins by the muscarinic agonist oxotremorine. Estimation of the binding parameters of GTP[S] in absence and presence of oxotremorine provided evidence for a catalytic activation of G proteins by agonist-activated muscarinic receptors in rat duodenal membranes and a strong signal amplification on the G protein level.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1538792     DOI: 10.1007/bf00175462

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

1.  Modulation of the structure-binding relationships of antagonists for muscarinic acetylcholine receptor subtypes.

Authors:  E K Pedder; P Eveleigh; D Poyner; E C Hulme; N J Birdsall
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

2.  Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia.

Authors:  D M Weiner; A I Levey; M R Brann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Characterization of the muscarinic receptor subtype mediating contractions of the guinea-pig uterus.

Authors:  R M Eglen; A D Michel; R L Whiting
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

Review 4.  Muscarinic receptor differentiation.

Authors:  F Mitchelson
Journal:  Pharmacol Ther       Date:  1988       Impact factor: 12.310

5.  Affinity spectra: a novel way for the evaluation of equilibrium binding experiments.

Authors:  H J Tobler; G Engel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-04       Impact factor: 3.000

6.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

7.  Functional determination of McN-A-343 affinity for M1 muscarinic receptors.

Authors:  R Micheletti; A Schiavone
Journal:  J Pharmacol Exp Ther       Date:  1990-04       Impact factor: 4.030

8.  4-DAMP analogues reveal heterogeneity of M1 muscarinic receptors.

Authors:  R Micheletti; L Giudici; M Turconi; A Donetti
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

9.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

10.  Antagonist binding profiles of five cloned human muscarinic receptor subtypes.

Authors:  F Dörje; J Wess; G Lambrecht; R Tacke; E Mutschler; M R Brann
Journal:  J Pharmacol Exp Ther       Date:  1991-02       Impact factor: 4.030

View more
  4 in total

Review 1.  cAMP guided his way: a life for G protein-mediated signal transduction and molecular pharmacology-tribute to Karl H. Jakobs.

Authors:  Klaus Aktories; Peter Gierschik; Dagmar Meyer Zu Heringdorf; Martina Schmidt; Günter Schultz; Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-05-17       Impact factor: 3.000

2.  Signal transduction pathways of muscarinic receptors in circular smooth muscle from the rabbit caecum.

Authors:  P Cuq; R Magous; J P Bali
Journal:  Mol Cell Biochem       Date:  1994-11-09       Impact factor: 3.396

3.  Mechanisms mediating cholinergic antral circular smooth muscle contraction in rats.

Authors:  Helena-F Wrzos; Tarun Tandon; Ann Ouyang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

4.  Pharmacological characterization of acetylcholine-stimulated [35S]-GTP gamma S binding mediated by human muscarinic m1-m4 receptors: antagonist studies.

Authors:  S Lazareno; N J Birdsall
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.